OncoTraj releases a harmonized 813-patient dataset with audited splits for three tasks on osimertinib resistance, showing single-timepoint NGS features yield no model above chance while recovering a TP53 association.
Siegel, Kimberly D
2 Pith papers cite this work. Polarity classification is still indexing.
2
Pith papers citing it
years
2026 2verdicts
UNVERDICTED 2representative citing papers
A data-driven framework applies population-based bio-inspired algorithms to recalibrate and evolve a prostate cancer-specific comorbidities index, reporting up to 0.1 improvement in concordance index over the Charlson index.
citing papers explorer
-
OncoTraj: a public benchmark for longitudinal resistance prediction in EGFR-mutant non-small-cell lung cancer on osimertinib
OncoTraj releases a harmonized 813-patient dataset with audited splits for three tasks on osimertinib resistance, showing single-timepoint NGS features yield no model above chance while recovering a TP53 association.
-
Developing a novel Comorbidities Index for predicting 10-year mortality in Prostate Cancer patients: A computational data-driven approach
A data-driven framework applies population-based bio-inspired algorithms to recalibrate and evolve a prostate cancer-specific comorbidities index, reporting up to 0.1 improvement in concordance index over the Charlson index.